In the title compound, C 19 H 16 N 4 S, the pyrazolo [3,4-d]pyrimidine ring is close to being planar, with the greatest deviation from the mean plane being 0.023 (2) Å for the C atom bearing the thione S atom. The two phenyl rings are nearly perpendicular to the fused ring system [dihedral angles = 71.4 (2) and 78.1 (2) ], but are oriented in opposite directions; the dihedral angle between the phenyl rings is 32.22 (16) . In the crystal, linear supramolecular chains along [101] are sustained by C-HÁ Á ÁS interactions. 
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For pharmacological and biochemical properties of pyrazolo [1,5-a] pyrimidine, see: Orlikova et al. (2014) ; Yuan et al. (2013) ; Rashad et al. (2011) . For related structures, see : El Fal et al. (2013 ; Alsubari et al. (2011) ; Ramli et al. (2012) . 
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À0.11 (7) Table 1 Hydrogen-bond geometry (Å , ). (Farrugia, 2012) ; software used to prepare material for publication: PLATON (Spek, 2009 ) and publCIF (Westrip, 2010 (Orlikova et al., 2014; Yuan et al., 2013; Rashad et al., 2011) . The present paper is a continuation of our research work devoted to the development of pyrazolo [3,4-d] pyrimidine derivatives with potential pharmacological activities (El Fal et al., 2013; El Fal et al., 2014; Alsubari et al., 2011; Ramli et al., 2012) .
The molecule of the title compound is build up from two fused five-and six-membered heterocycles linked to two phenyl rings via two -CH 2 -groups as shown in Fig. 1 . The pyrazolo [3,4-d] pyrimidine system is virtually planar with the largest deviation from the mean plane being -0.023 (2) Å at C1 and makes dihedral angles of 71.4 (2)° and 78.1 (2)° with the mean plane through the first (C7 to C12) and the second (C14 to C19) phenyl rings, respectively. As a matter of fact, the two phenyl rings are oriented in opposite direction to the plane of the fused rings. No classic hydrogen bonds are observed in the present structure.
S2. Synthesis and crystallization
3.32 g (10 mmol) of 1,5-dibenzyl-1H, 4H, 5H-pyrazolo [3,4-d] pyrimidin-4-one is refluxed in pyridine (30 ml) with 5.55 g (25 mmol) of phosphorus pentasulfide for 4 h. Then the solvent was evaporated under reduced pressure. The precipitate that formed was washed with hot water to remove residual dimerized P 2 S 5 until colourless filtrate was noted. The solid was re-crystallized from ethanol to afford the title compound as yellow crystals (yield: 85%; m.p. = 563 K).
S3. Refinement
The H atoms were located in a difference map and treated as riding with C-H = 0.93 Å (aromatic) and C-H = 0.97 Å (methylene). All hydrogen with U iso (H) = 1.2 U eq (aromatic and methylene). Two reflections, i.e. 0 -2 0 and 0 2 0, were omitted fro the final refinement owing to poor agreement.
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Figure 1
Molecular structure of the title compound with the atom-labelling scheme. Displacement ellipsoids are drawn at the 50% probability level. H atoms are represented as small circles.
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